COVID-19 Updates
From the Journals
Immune response may explain brain damage after COVID-19
Antibodies appear involved in an attack on the cells lining the brain’s blood vessels.
Latest News
Biden tests positive for COVID-19: White House
President Biden plans to isolate at the White House and “will continue to carry out all of his duties fully during that time.”
From the Journals
COVID-19 infection late in pregnancy linked to sevenfold risk of preterm birth
The later in pregnancy COVID-19 infection occurs, the more likely preterm birth appears to be.
From the Journals
Pre-endoscopy COVID-19 testing may not be needed
Personal protective equipment and COVID-19 vaccination might be enough to reduce COVID-19 transmission.
From the Journals
RV dysfunction slams survival in acute COVID, flu, pneumonia
The findings suggest that abnormal RV findings should be considered a mortality risk marker in patients with acute respiratory illness.
Feature
Methotrexate’s impact on COVID-19 vaccination: New insights made
New studies assess patients with various immune-mediated inflammatory diseases to determine the risks and benefits of pausing methotrexate after...
Latest News
Many people becoming reinfected as BA.5 dominates new COVID-19 cases
Prior infections and vaccines aren’t providing as much protection against the newly dominant BA.5 strain as they did against earlier variants.
Latest News
Some have heavier periods after COVID vaccine
Many women are reporting that they have had heavier bleeding during their periods in the months after they received their COVID shots. But...
From the Journals
Cancer drug significantly cuts risk for COVID-19 death
The data are “pretty impressive and in a group of patients that we really have limited things to offer.”
Livin' on the MDedge
Shift schedule today could worsen that stroke tomorrow
Plus: Feed your soul with online art, feed your “hangry” etymologist, but don’t feed anyone with SARS-CoV-2 from the freezer.
News from the FDA/CDC
FDA grants emergency authorization for Novavax COVID vaccine
Clinical trials found the vaccine to be 90.4% effective in preventing mild, moderate or severe COVID-19.